AAFP News |
FDA Warns of Amputation Risk Linked to Newer Diabetes Drug
AAFP News Marketed as single-ingredient products or in combination with other diabetes drugs such as metformin, SGLT2 inhibitors are FDA-approved for use in conjunction with diet and exercise to lower blood glucose in patients with type 2 diabetes ... Amputation risk possible with diabetes drugs, FDA warns |
Social Plugin